Gnosis by Lesaffre unveils future of fermentation-powered health and wellness
25 Jun 2025 | Gnosis by Lesaffre
We caught up with Ulrich Irgens, the general manager at Gnosis by Lesaffre, at the recent Vitafoods Europe 2025 trade show to discuss how the company is pioneering the future of health through fermentation and biotransformation. In this interview, the company shares how its pharma-grade precision meets natural innovation in ingredients like MyCondro, Quatrefolic, and MenaQ7 Matrix, while highlighting the unique power of probiotic yeasts and where fermentation is headed next in joint, gut, and systemic health.
Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot

Top Nutrition Trends 2027
Nutrition Insight















